GeneType , Stayhealthy announce distribution agreement for multi-risk test

Genetic Technologies and Stayhealthy announce a major distribution agreement. This partnership will bring GTG’s innovative Multi-Risk Test to a broader audience in the online pharmacy channel across North America, empowering individuals to take control of their health. GeneType will now distribute the Multi-Risk Test via StayHealthyRx, enhancing the reach of its portfolio of personalized health risk assessments across North America. This collaboration will provide users with comprehensive insights into their health risks and actionable steps to mitigate them. “Partnering with GeneType allows us to reach more people with Gene Types Multi-Risk Test, offering a powerful tool for health management,” said John Collins, CEO of Stayhealthy. “GeneType’s expertise in non-invasive genetic testing complements our technology perfectly.”